PATENT CLAIM ANALYSIS

Application Number: 16007046
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "006200"]

Abstract:
Insulin dimers and insulin analog dimers that act as partial agonists at the insulin receptor are disclosed.

Claim (Index 82):
An insulin dimer comprising:\n (a) a first B29 or B28 Lys of a first insulin heterodimer molecule having a first A-chain polypeptide and first B-chain polypeptide and a second B29 or B28 Lys of a second insulin heterodimer having a second A-chain polypeptide and second B-chain polypeptide conjugated together by a bifunctional linker selected from the group consisting of:

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14945461', '16301010', '14431040', '14504476', '15191584']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8019489295061857
- 35 USC 102 Novelty (BERT): 0.6508510252638373
- Combined Prediction Score: 0.7868391390819509
- Mean Citation Score: 447.387708
- Max Citation Score: 682.5196
- Similarity Product: 581.0273090075493

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test